MapLight Therapeutics Inc.
MPLT | NASDAQ
$10.90
-$0.02 (-0.18%)
At close: Sep 21, 2026, 4:00 PM ET
$11.20
+$0.30 (+2.75%)
After-hours:
Sep 21, 2026, 6:22 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
PE Ratio | -4.80 | -9.81 | -13.69 | -25.47 |
PEG Ratio | -0.05 | -0.25 | -0.16 | n/a |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 1.69 | 6.60 | 10.66 | 36.41 |
P/FCF Ratio | -5.58 | -9.55 | -14.48 | -27.81 |
P/OCF Ratio | -5.60 | -9.64 | -14.61 | -28.59 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.06 | 0.08 | 0.30 |
Quick Ratio | 20.01 | 7.20 | 5.69 | 2.54 |
Current Ratio | 20.01 | 7.20 | 5.69 | 2.54 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity | -35.16% | -67.35% | -78.15% | -143.82% |
Return on Assets | -33.61% | -56.66% | -60.94% | -76.20% |
Return on Invested Capital | -36.43% | -68.11% | -74.19% | -115.12% |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MPLT